TMO adds important new tests

Article Excerpt

THERMO FISHER SCIENTIFIC INC., $525.69, is a buy. The company (New York symbol TMO; TSINetwork Rating: Average) (www.thermofisher.com; Shares o/s: 391.8 million; Market cap: $208.5 billion; Dividend yield: 0.2%) recently gained FDA clearance for advanced blood tests that can help detect wheat and sesame allergies for patients at risk of a severe allergic reaction. The new test can help identify patients with a sesame allergy who are at risk of a severe anaphylactic reaction. And despite being the third most common food allergy, wheat is often misdiagnosed and confused with other digestive disorders like gluten intolerance and celiac disease. The new test can help patients avoid unnecessary diet restrictions. Thermo Fisher is a buy. buy. …